Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington, shared a post on X:
“Kudos to Leo Rasche Marc Raab et al for saying quiet part out loud. Given importance of bridging therapy (BT) to CAR-T outcomes in myeloma (Surbhi Sidana et al), should we consider extending BT prn to debulk further?
Results of consensus panel, now in BMT journal: Yes!”
Title: Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma
Authors: Leo Rasche, Maria Theresa Krauth, Hermine Agis, Christoph Renner, Irene Strassl,
Raphael Teipel, Vladan Vučinić, Katja Weisel, Wolfgang Willenbacher, Marc S. Raab.
Read the full article on Bone Marrow Transplantation.
Other articles about Multiple Myeloma on OncoDaily.
